Zura Bio (ZURA) Current Assets (2021 - 2026)
Zura Bio (ZURA) posted quarterly Current Assets of $227.0 million for Q1 2026, up 32.22% year-over-year from $171.7 million in Q1 2025, and up 102.12% quarter-over-quarter from $112.3 million in Q4 2025.
Zura Bio (ZURA) Current Assets (2021 - 2026) Analysis & Trends
Zura Bio's Current Assets history runs 6 years deep, the most recent figure standing at $227.0 million for Q1 2026.
- In Q1 2026, Current Assets rose 32.22% year-over-year to $227.0 million; the TTM figure through Mar 2026 stood at $227.0 million (up 32.22% YoY), while the FY2025 annual figure was $112.3 million, down 37.17% from the prior year.
- Current Assets for Q1 2026 stood at $227.0 million, up from $112.3 million in the prior quarter.
- The five-year high for Current Assets was $227.0 million in Q1 2026, with the low at $196655.0 in Q3 2022.
- The 5-year median for Current Assets is $112.3 million (2025), against an average of $107.3 million.
- The sharpest annual moves came in 2023 and 2025: Current Assets soared 53085.53% in 2023, then plunged 37.17% in 2025.
- Zura Bio's Current Assets stood at $1.8 million in 2022, then jumped by 5578.1% to $100.8 million in 2023, then soared by 77.25% to $178.7 million in 2024, then slumped by 37.17% to $112.3 million in 2025, then soared by 102.12% to $227.0 million in 2026.
- Business Quant data shows ZURA's Current Assets at $227.0 million in Q1 2026, $112.3 million in Q4 2025, and $142.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Zura Bio | 706.30 Mn | 706.30 Mn | - | 210.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 210.50 Mn |
| Mar 31, 2026 | 227.00 Mn |
| Dec 31, 2025 | 112.31 Mn |
| Sep 30, 2025 | 142.29 Mn |
| Jun 30, 2025 | 156.99 Mn |
| Mar 31, 2025 | 171.69 Mn |
| Dec 31, 2024 | 178.74 Mn |
| Sep 30, 2024 | 188.98 Mn |
| Jun 30, 2024 | 189.48 Mn |
| Mar 31, 2024 | 90.47 Mn |
| Dec 31, 2023 | 100.84 Mn |
| Sep 30, 2023 | 104.59 Mn |
| Jun 30, 2023 | 113.33 Mn |
| Mar 31, 2023 | 44.39 Mn |
| Dec 31, 2022 | 1.78 Mn |
| Sep 30, 2022 | 196,655.00 |
| Jun 30, 2022 | 436,598.00 |
| Mar 31, 2022 | 836,951.00 |
| Dec 31, 2021 | 1.15 Mn |